The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
Alzheimer's disease (AD) is the most common form of dementia, and its incidence increases with age. Treatment with cholinesterase inhibitor drugs is currently the standard of care. Several other medications and nonpharmacologic therapies are also available for the treatment of cognitive decline and other symptoms of AD. This article reviews the current recommendations for the treatment of Alzheimer's disease.
Hake
Ann Marie
AM
Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000628:therapy; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001521:Behavior Therapy; D017028:Caregivers; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D016166:Free Radical Scavengers / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D018697:Nootropic Agents / Q000627:therapeutic use*; D014810:Vitamin E / Q000627:therapeutic use
D000927:Anticonvulsants; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D016166:Free Radical Scavengers; D018697:Nootropic Agents; D014810:Vitamin E